UNSPSC 51383504: Ketorolac

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51383504

Definition

This classification denotes a cyclooxygenase inhibitor with the molecular formula C15H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YZI5105V0L, chemically known as 5-benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxylic acid but generally known as ketorolac, which bears US NIH Compound Identifier 3826. European Medicines Agency schedules Ketorolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08376MIG.

Read the full definition

The term KETOROLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules ketorolac in its Anatomical Therapeutic Chemical (ATC) Classification. KETOROLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ketorolac under HS 29339990 and SITC 51577. As of Q4 2014, KETOROLAC remains the US FDA Preferred Term for this commodity. Ketorolac bears US NLM identifiers UMLS ID C0073631 and NCI Concept Code C1219.

SMILES: OC(=O)C1CCN2C1CCC2C(=O)C1CCCCC1.

About UNSPSC 51383504

UNSPSC 51383504 Ketorolac is a Commodity code that covers pharmaceutical products, though the recent state and local procurement activity tagged to this code does not reflect ketorolac purchases. Instead, Seminole County, Florida solicited naloxone and drug deactivation systems—a scope mismatch that signals either a tagging error or a broader pharmaceutical and medical-supply categorization at the state-local level. State and local governments buying under this code tier are acquiring specific pharmaceutical items or related medical supplies to support community health, public safety, or emergency-response initiatives. Issuing bodies include county health departments and public health systems that procure these items through competitive bid processes for quarterly or regular delivery to designated facilities.

Seminole County, Florida represents the primary recent activity on record. The county issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with a response deadline of July 26, 2023. The procurement required electronic submission through the county's e-Procurement Portal, included delivery and shipping costs in the bid, and specified a two-year initial term with a one-year renewal option. Bidders faced standard compliance requirements including drug-free workplace certification, E-Verify, appropriate insurance coverage, and potential FEMA-related federal regulations. The contract incorporated a three-month probationary termination clause. Beyond this single opportunity, the source does not support additional recent state or local solicitations under this code.

Quick answers

What is UNSPSC 51383504?

UNSPSC 51383504 is Ketorolac, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51383504?

UNSPSC 51383504 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51383504

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code